{"id":17568,"date":"2016-03-24T00:00:00","date_gmt":"2016-03-24T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/"},"modified":"2016-03-24T00:00:00","modified_gmt":"2016-03-24T00:00:00","slug":"mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/fr\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/","title":{"rendered":"Mallinckrodt se joint aux coalitions CADCA pour demander un soutien au programme de surveillance des m\u00e9dicaments sur ordonnance du Missouri"},"content":{"rendered":"<p>La soci\u00e9t\u00e9 biopharmaceutique Mallinckrodt a exprim\u00e9 publiquement son soutien \u00e0 la cr\u00e9ation d&#039;un programme de surveillance des m\u00e9dicaments sur ordonnance (PDMP) dans le Missouri, o\u00f9 se trouve son si\u00e8ge social aux \u00c9tats-Unis.<\/p>\n<p>Dans une annonce dans les journaux de l&#039;\u00c9tat, Mallinckrodt a r\u00e9cemment publi\u00e9 une lettre ouverte aux habitants du Missouri pour leur demander d&#039;exhorter leurs l\u00e9gislateurs \u00e0 adopter la loi sur le contr\u00f4le des stup\u00e9fiants (HB 1892) d\u00e8s que possible.<\/p>\n<p>\u00ab Selon le minist\u00e8re de la Sant\u00e9 et des Services aux personnes \u00e2g\u00e9es du Missouri, les d\u00e9c\u00e8s dus aux m\u00e9dicaments sur ordonnance ont plus que quadrupl\u00e9 dans le Missouri au cours des 10 derni\u00e8res ann\u00e9es, cr\u00e9ant une pression sur nos familles et nos communaut\u00e9s. Avoir un PDMP solide dans chaque \u00c9tat est l\u2019une des principales recommandations des Centers for Disease Control and Prevention des \u00c9tats-Unis afin de r\u00e9duire l\u2019abus d\u2019analg\u00e9siques. En tant que seul \u00c9tat du pays sans PDMP, le Missouri ne dispose pas d\u2019un outil essentiel pour lutter contre ce grave probl\u00e8me \u00bb, indique la lettre.<\/p>\n<p>Natalie Newville, responsable de l&#039;information publique pour ACT Missouri, qui est la coalition de coalitions \u00e0 l&#039;\u00e9chelle de l&#039;\u00c9tat et l&#039;une des centaines de coalitions qui travaillent \u00e0 l&#039;\u00e9laboration et \u00e0 la r\u00e9vision du texte du projet de loi depuis plusieurs ann\u00e9es, fonde de grands espoirs sur la derni\u00e8re it\u00e9ration des chances du projet de loi. de passer bient\u00f4t. En outre, leur coalition a travaill\u00e9 avec la coalition PDMP Now sur le plaidoyer.<\/p>\n<p>&quot;<a href=\"https:\/\/www.actmissouri.org\/?s=PDMP\" target=\"_blank\" rel=\"noopener\">Le projet de loi PDMP<\/a> contribuera \u00e0 fournir des soins de qualit\u00e9 et la qualit\u00e9 de vie s&#039;am\u00e9liorera gr\u00e2ce \u00e0 un outil comme celui-ci car, m\u00eame si ce n&#039;est pas la solution miracle, si nous voulons mettre fin \u00e0 la consommation d&#039;h\u00e9ro\u00efne et \u00e0 l&#039;abus de Rx dans notre \u00c9tat, cela nous donnera un outil pour continuez \u00e0 r\u00e9soudre le probl\u00e8me dans le Missouri \u00bb, a d\u00e9clar\u00e9 Newville.<\/p>\n<p>Le membre du CADCA a d\u00e9clar\u00e9 que sa coalition travaille \u00e0 l&#039;\u00e9laboration de strat\u00e9gies suppl\u00e9mentaires pour lutter contre l&#039;abus de m\u00e9dicaments sur ordonnance dans le Missouri. Sa coalition a rencontr\u00e9 certains dirigeants de Mallinckrodt lors du r\u00e9cent Forum national du leadership de la CADCA et a discut\u00e9 de la collaboration sur les questions d&#039;\u00e9limination des m\u00e9dicaments. De plus, Saint-Louis a \u00e9t\u00e9 nomm\u00e9e l&#039;une des villes de la strat\u00e9gie DEA 360 en raison de son probl\u00e8me d&#039;h\u00e9ro\u00efne.<\/p>\n<p><strong>VOIR \u00c9GALEMENT:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cadca.org\/fr\/news\/medicine-safety-drug-disposal-and-storage\/\" target=\"_blank\" rel=\"noopener\">Le nouveau cours en ligne de CADCA pour lutter contre les abus Rx et OTC<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Biopharmaceutical company Mallinckrodt has expressed its support publicly regarding establishing a Prescription Drug Monitoring Program (PDMP) in\u00a0Missouri, the location of<\/p>","protected":false},"author":23,"featured_media":0,"template":"","resource_type":[281],"drug_specific_issues":[307],"action_to_do":[],"class_list":["post-17568","resource","type-resource","status-publish","hentry","resource_type-coalitions-online","drug_specific_issues-prescription-and-over-the-counter-medications"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/fr\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program | CADCA\" \/>\n<meta property=\"og:description\" content=\"Biopharmaceutical company Mallinckrodt has expressed its support publicly regarding establishing a Prescription Drug Monitoring Program (PDMP) in\u00a0Missouri, the location of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/fr\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\\\/\",\"name\":\"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"datePublished\":\"2016-03-24T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/fr\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/","og_locale":"fr_FR","og_type":"article","og_title":"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program | CADCA","og_description":"Biopharmaceutical company Mallinckrodt has expressed its support publicly regarding establishing a Prescription Drug Monitoring Program (PDMP) in\u00a0Missouri, the location of","og_url":"https:\/\/www.cadca.org\/fr\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/","og_site_name":"CADCA","og_image":[{"width":880,"height":500,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/","url":"https:\/\/www.cadca.org\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/","name":"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"datePublished":"2016-03-24T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/mallinckrodt-joins-cadca-coalitions-in-urging-support-for-missouris-prescription-drug-monitoring-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Mallinckrodt Joins CADCA Coalitions in Urging Support for Missouri\u2019s Prescription Drug Monitoring Program"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17568\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/media?parent=17568"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource_type?post=17568"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/drug_specific_issues?post=17568"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/action_to_do?post=17568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}